4//SEC Filing
LOAR MATTHEW M 4
Accession 0001209191-18-039169
CIK 0000908259other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:12 PM ET
Size
8.4 KB
Accession
0001209191-18-039169
Insider Transaction Report
Form 4
LOAR MATTHEW M
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-06-20+500,000→ 500,000 totalExercise: $0.22Exp: 2028-06-20→ Common Stock (500,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-06-20+250,000→ 250,000 totalExercise: $0.22Exp: 2028-06-20→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Mr. Loar was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "2017 Plan Options"), pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as Chief Financial Officer.
- [F2]The Options will vest in twelve equal monthly installments beginning one month after the date of grant.
- [F3]Mr. Loar was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "2015 Plan Options" and, collectively with the 2017 Plan Options, the "Options"), pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan in connection with his service as Chief Financial Officer.
Documents
Issuer
MATEON THERAPEUTICS INC
CIK 0000908259
Entity typeother
Related Parties
1- filerCIK 0001236260
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:12 PM ET
- Size
- 8.4 KB